Skip to content
HowShorted

AnaptysBio, Inc. short interest in 2020

In 2020, AnaptysBio, Inc.'s disclosed short interest ran from 16.28% of shares outstanding on 15 Jan 2020 to 12.89% on 31 Dec 2020, a change of -3.39 percentage points. The year's high was 22.92% on 15 Apr 2020 and its low 12.89% on 31 Dec 2020, averaging 18.26% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 30.04 days on 31 Jul 2020. Full history: AnaptysBio, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for AnaptysBio, Inc. in 2020

2020 in figures

Start of year
16.28% (15 Jan 2020)
End of year
12.89% (31 Dec 2020)
Change
-3.39 pp
High
22.92% (15 Apr 2020)
Low
12.89% (31 Dec 2020)
Average
18.26%
Highest days to cover
30.04 (31 Jul 2020)
SEC filings marked
8

Every report in 2020

AnaptysBio, Inc. short interest in 2020
SettlementShort interestDays to coverFilings since previous
15 Jan 202016.28%9.06
31 Jan 202018.55%10.37
14 Feb 202019.33%10.89
28 Feb 202020.68%8.41
13 Mar 202021.87%8.6210-K filed, results (8-K)
31 Mar 202022.81%9.68
15 Apr 202022.92%13.24
30 Apr 202022.42%17.47
15 May 202022.89%16.5810-Q filed, results (8-K)
29 May 202021.83%20.78
15 Jun 202021.35%14.44
30 Jun 202018.79%11.41
15 Jul 202018.50%27.23
31 Jul 202017.86%30.04
14 Aug 202017.48%28.4110-Q filed, results (8-K)
31 Aug 202016.84%28.87
15 Sep 202016.91%22.78
30 Sep 202015.75%16.01
15 Oct 202016.31%13.09
30 Oct 202014.44%7.86
13 Nov 202014.53%11.3110-Q filed, results (8-K)
30 Nov 202013.74%14.63
15 Dec 202013.33%16.82
31 Dec 202012.89%17.33

See also: AnaptysBio, Inc.'s full history · most shorted US stocks of 2020 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.